Suppr超能文献

PNPLA3及其变体在肝脏疾病中的研究进展、挑战与展望

Research progress, challenges and perspectives on PNPLA3 and its variants in Liver Diseases.

作者信息

Xiang Hongjiao, Wu Zecheng, Wang Junmin, Wu Tao

机构信息

Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

出版信息

J Cancer. 2021 Aug 13;12(19):5929-5937. doi: 10.7150/jca.57951. eCollection 2021.

Abstract

The human patatin-like phospholipase domain-containing 3 gene (PNPLA3) is highly expressed in liver and adipose tissue and encodes a transmembrane polypeptide chain containing 481 amino acids. The I148M variant of PNPLA3 is a single nucleotide polymorphism, which is related to a variety of liver and cardiovascular diseases and their complications (such as non-alcoholic fatty liver disease, liver fibrosis, coronary artery disease). This review mainly describes the pathophysiological effects of PNPLA3 and its variants, and their roles in the progression of liver disease and its complications.

摘要

人类含帕他汀样磷脂酶结构域蛋白3基因(PNPLA3)在肝脏和脂肪组织中高度表达,编码一条含481个氨基酸的跨膜多肽链。PNPLA3的I148M变异体是一种单核苷酸多态性,与多种肝脏和心血管疾病及其并发症(如非酒精性脂肪性肝病、肝纤维化、冠状动脉疾病)相关。本文综述主要描述了PNPLA3及其变异体的病理生理效应,以及它们在肝脏疾病及其并发症进展中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a816/8408107/30235377b2e4/jcav12p5929g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验